Innovative partnership focuses on early-stage development of activators for a glucose detoxification enzyme called glycerol-3-phosphate phosphatase (G3PP) MONTREAL, July 20, 2021 /PRNewswire/ — NIMIUM Therapeutics (www.nimium.ca), a Montreal-based biotech, has formed a partnership with Paraza Pharma (www.parazapharma.com) to develop a new treatment for cardiometabolic diseases (CMDs). The treatment aims to prevent and reverse the adverse […]